Summary
- Current Price
- As of today, AGIO price is $33.32, down -2.80% on
- Current Price All-Time High
- AGIO price is currently -76.00% below its historical high of $138.85 set on
- Market Cap
- AGIO current market cap is $2B, down -10.23% year-over-year
- Revenue
- AGIO current annual revenue is $54.03M, up +48.03% year-over-year
- Next Earnings
- The next earnings release for AGIO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Agios Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AGIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | agios.com |
| Employees | 486 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $33.32 | |
| Price, 1D Change | -2.80% | |
| $2B | ||
| - | ||
| - | ||
| 0.52 | ||
| $54.03M | ||
| Revenue, 1Y Change | +48.03% | |
| -$7.12 | ||
| EPS, 1Y Change | -161.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$7.12 | ||
| EPS Estimate | -$5.63 | N/A |
| EPS Est. Change | +20.88% | N/A |
| $54.03M | ||
| Revenue Estimate | $182.49M | N/A |
| Revenue Est. Change | +237.78% | N/A |
| Current Price | $33.32 | |
| Price Target | $42.50 | - |
| Price Tgt. Change | +27.55% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.21 | $11.64 | +3.82% | |
| -$7.01 | -$7.12 | -1.57% | |
| -$5.63 | N/A | +20.88% | |
| -$3.86 | N/A | +45.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $35.16M | $36.50M | +3.79% | |
| $46.12M | $54.03M | +17.14% | |
| $182.49M | N/A | +237.78% | |
| $339.85M | N/A | +529.02% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $33.32 | |
| $30.76 | ||
| $35.83 | ||
| $32.72 | ||
| $33.99 | ||
| -$0.32 | ||
| 0.52 | ||
| $1.48 | ||
| 46.35 | ||
| 39.45% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $54.03M | ||
| -$7.12 | ||
| $42.51M | ||
| 78.67% | ||
| -$472.13M | ||
| -873.87% | ||
| -$412.78M | ||
| -764.01% | ||
| -$466.96M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 11.46 | ||
| 11.06 | ||
| - | ||
| 4 | ||
| 10.49 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 20.23 | ||
| 1.94 | ||
| -3.09 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.19B | ||
| $854.43M | ||
| $1.30B | ||
| $942.05M | ||
| $104.11M | ||
| $82.21M | ||
| $40.21M | ||
| $18.39M | ||
| $18.36M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $466.81M | ||
| $514.64M | ||
| $11.52M | ||
| $180.28M | ||
| $5.18M | ||
| $0.00 | ||
| -$1.02M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$372.98M | ||
| $377.18M | ||
| $8.68M | ||
| $4.32M | ||
| -$377.29M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Truist Securities | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
No data
Screeners with AGIO
FAQ
- What is the ticker symbol for Agios Pharmaceuticals, Inc.?
- The ticker symbol for Agios Pharmaceuticals, Inc. is NASDAQ:AGIO
- Does Agios Pharmaceuticals, Inc. pay dividends?
- No, Agios Pharmaceuticals, Inc. does not pay dividends
- What sector is Agios Pharmaceuticals, Inc. in?
- Agios Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Agios Pharmaceuticals, Inc. in?
- Agios Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Agios Pharmaceuticals, Inc. based in?
- Agios Pharmaceuticals, Inc. is headquartered in United States
- When did Agios Pharmaceuticals, Inc. go public?
- Agios Pharmaceuticals, Inc. initial public offering (IPO) was on July 24, 2013
- Is Agios Pharmaceuticals, Inc. in the S&P 500?
- No, Agios Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Agios Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Agios Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Agios Pharmaceuticals, Inc. in the Dow Jones?
- No, Agios Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Agios Pharmaceuticals, Inc. last earnings report?
- Agios Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
- When does Agios Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Agios Pharmaceuticals, Inc. is October 29, 2026
Data Sources & References
- AGIO Official Website www.agios.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1439222/000143922226000025/0001439222-26-000025-index.htm
- AGIO Profile on Yahoo Finance finance.yahoo.com/quote/AGIO
- AGIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agio